Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Covalent Laboratories Private Limited provides pharmaceutical products
Covalent Laboratories Private Limited, is an unlisted private company incorporated on 13 September, 2002. It is classified as a private limited company and is located in Hyderabad., Telangana. It's authorized share capital is INR 20.00 cr and the total paid-up capital is INR 6.00 cr.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Read more
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | 1,535.8 | 1,465.7 | 1,802.0 | 2,217.0 | 2,916.1 |
Operating profit | 149.3 | 131.7 | 97.9 | 80.0 | 298.6 |
Net profit | 76.1 | 73.0 | 52.5 | 35.0 | 206.4 |
Gross margin | 21.9 | 24.3 | 18.6 | 17.6 | 23.2 |
Operating margin | 9.7 | 9.0 | 5.4 | 3.6 | 10.2 |
Net margin | 5.0 | 4.9 | 2.9 | 1.6 | 7.0 |
Networth | 306.0 | 379.1 | 431.8 | 466.8 | 673.0 |
Borrowings | 180.4 | 147.0 | 145.3 | 126.4 | 91.6 |
Assets | 952.4 | 912.9 | 1,040.3 | 1,282.9 | 1,512.8 |
Debt to equity | 0.6 | 0.4 | 0.3 | 0.3 | 0.1 |
Current ratio | 1.2 | 1.3 | 1.4 | 1.3 | 1.5 |
ROE | 24.9 | 19.3 | 12.2 | 7.5 | 30.7 |
Days payable | 128.0 | 117.0 | 103.0 | 133.0 | 113.0 |
WC days | 24.0 | 39.0 | 44.0 | 40.0 | 52.0 |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | 6.0 | 6.0 | 6.0 | 6.0 | 6.0 |
Reserves | 300.0 | 373.1 | 425.8 | 460.8 | 667.0 |
Borrowings + | 180.4 | 147.0 | 145.3 | 126.4 | 91.6 |
Long term borrowings | 66.0 | 20.7 | 14.9 | 10.3 | 17.6 |
Short term borrowings | 114.4 | 126.3 | 130.5 | 116.2 | 74.0 |
Trade payables + | 419.4 | 356.9 | 415.0 | 664.0 | 691.6 |
Days payable | 128.0 | 117.0 | 103.0 | 133.0 | 113.0 |
Other liabilities + | 466.0 | 386.7 | 463.2 | 689.7 | 748.2 |
Other non-current liabilities | 11.5 | 11.6 | 11.0 | 9.6 | 8.4 |
Other current liabilities | 35.1 | 18.3 | 37.1 | 16.1 | 48.1 |
Total liabilities | 952.4 | 912.9 | 1,040.3 | 1,282.9 | 1,512.8 |
Fixed Assets + | 261.9 | 236.9 | 221.2 | 232.2 | 273.3 |
Tangible assets | 257.9 | 236.7 | 212.7 | 190.8 | 254.2 |
CWIP | 3.8 | - | 8.3 | 41.2 | 19.0 |
Intangible assets | 0.3 | 0.2 | 0.1 | 0.1 | - |
LT loans and advances | - | - | - | - | - |
Other non-current assets | 20.5 | 18.4 | 21.3 | 12.8 | 13.3 |
Current assets + | 670.0 | 657.5 | 797.8 | 1,038.0 | 1,226.2 |
Inventories | 142.0 | 192.9 | 180.2 | 187.6 | 215.9 |
Trade receivables | 489.6 | 401.9 | 592.7 | 703.5 | 885.7 |
Cash and cash equivalents | 7.9 | 10.2 | 7.0 | 73.7 | 46.9 |
ST loans and advances | 0.1 | - | 0.1 | 0.1 | 0.2 |
Other current assets | 30.4 | 52.4 | 17.8 | 73.0 | 77.6 |
Total assets | 952.4 | 912.9 | 1,040.3 | 1,282.9 | 1,512.8 |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales + | 1,535.8 | 1,465.7 | 1,802.0 | 2,217.0 | 2,916.1 |
Sales growth % | 33.07 | -4.56 | 22.94 | 23.03 | 31.53 |
Expenses + | 1,442.9 | 1,377.3 | 1,741.6 | 2,175.7 | 2,654.3 |
Cost of goods | 1,200.2 | 1,109.8 | 1,467.8 | 1,828.0 | 2,238.1 |
Employee cost | 37.1 | 40.2 | 43.9 | 44.9 | 87.2 |
Other costs | 149.2 | 184.1 | 192.4 | 264.2 | 292.2 |
Operating profit + | 149.3 | 131.7 | 97.9 | 80.0 | 298.6 |
Operating margin % | 9.7 | 9.0 | 5.4 | 3.6 | 10.2 |
Other income | 3.4 | 10.8 | 10.6 | 9.0 | 16.2 |
Interest | 21.7 | 11.4 | 8.5 | 12.4 | 7.1 |
Depreciation | 34.7 | 31.8 | 29.1 | 26.2 | 29.7 |
Exceptional items | - | - | - | - | - |
Profit before tax | 96.3 | 99.2 | 70.9 | 50.3 | 278.0 |
Tax | 20.2 | 26.2 | 18.4 | 15.2 | 71.6 |
Profit - disc. ops | - | - | - | - | - |
Net profit | 76.1 | 73.0 | 52.5 | 35.0 | 206.4 |
Net margin % | 5.0 | 4.9 | 2.9 | 1.6 | 7.0 |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Solvency + | |||||
Total Debt/Equity | 0.6 | 0.4 | 0.3 | 0.3 | 0.1 |
Net Debt/Equity | 0.6 | 0.4 | 0.3 | 0.1 | 0.1 |
Total Debt/Assets | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 |
Total Assets/Equity | 3.1 | 2.4 | 2.4 | 2.8 | 2.2 |
Liquidity + | |||||
Current Ratio | 1.2 | 1.3 | 1.4 | 1.3 | 1.5 |
Quick Ratio | 0.9 | 0.9 | 1.1 | 1.1 | 1.2 |
Interest Coverage | 6.9 | 11.5 | 11.6 | 6.4 | 42.0 |
Performance | |||||
Gross Margin | 21.9 | 24.3 | 18.6 | 17.6 | 23.2 |
Operating Margin | 9.7 | 9.0 | 5.4 | 3.6 | 10.2 |
Net Margin | 5.0 | 4.9 | 2.9 | 1.6 | 7.0 |
Return + | |||||
Return on Equity | 24.9 | 19.3 | 12.2 | 7.5 | 30.7 |
Pre-tax ROCE | 31.6 | 25.4 | 15.8 | 11.3 | 39.2 |
Return on Assets | 8.0 | 8.0 | 5.0 | 2.7 | 13.7 |
Pre-tax ROIC | 23.9 | 19.4 | 12.1 | 10.3 | 37.5 |
Efficiency + | |||||
Days Payable | 128.0 | 117.0 | 103.0 | 133.0 | 113.0 |
Days Inventory | 43.0 | 63.0 | 45.0 | 37.0 | 35.0 |
Days Receivable | 116.0 | 100.0 | 120.0 | 116.0 | 111.0 |
Fixed Asset Turnover | 5.9 | 6.2 | 8.2 | 9.6 | 10.7 |
Total Asset Turnover | 1.6 | 1.6 | 1.7 | 1.7 | 1.9 |
Working Capital | |||||
Cash Conversion Cycle | 31.0 | 46.0 | 62.0 | 20.0 | 33.0 |
Working Capital Days | 24.0 | 39.0 | 44.0 | 40.0 | 52.0 |
State Bank of India
No. of Loans: 1
Total Amount : 196.2 cr
CitiBank N.A.
No. of Loans: 2
Total Amount : 80.0 cr
HDFC Bank Limited
No. of Loans: 1
Total Amount : 63.0 cr
RBL Bank Limited
No. of Loans: 1
Total Amount : 60.0 cr
Kotak Mahindra Bank Limited
No. of Loans: 1
Total Amount : 50.0 cr
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Narayana Reddy Mundla
Shareholder
|
00064392 | 22 years |
Managing Director | Madireddy Narayana Reddy
Shareholder
|
00123201 | 23 years |
Whole-time Director | Maddireddy Vijaykiran
Shareholder
|
01095484 | 23 years |
Director | Prasanth Nandigala
Shareholder
|
01740471 | 22 years |
Director | Mundla Maha Vishnu | 02470664 | 1 years |
Director | Abhinav Reddy Nandigala | 10362886 | 1 years |
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
EMMENNAR CHEM PRIVATE LIMITED |
Amalgamated
|
5.0 Cr | 2 | Telangana |
SV'S REMEDIES LIMITED |
Amalgamated
|
12.2 Cr | 3 | Telangana |
VIRCHOW BIOTECH PRIVATE LIMITED |
Active
|
17.0 Cr | 1 | Telangana |
ANDHRA ORGANICS LIMITED |
Active
|
4.5 Cr | 3 | Telangana |
VIRCHOW HEALTHCARE PRIVATE LIMITED |
Active
|
2.0 Cr | 1 | Maharashtra |
VIRCHOW LABORATORIES LIMITED |
Active
|
75.0 L | 3 | Telangana |
VIRCHOW PETROCHEMICAL PRIVATE LIMITED |
Active
|
2.8 Cr | 3 | Telangana |
IMEX ENGINEERING CO PVT LTD |
Active
|
39.6 L | 2 | Telangana |
VIRCHOW DRUGS LIMITED |
Active
|
12.2 Cr | 2 | Telangana |
CYCLIC LIFE SCIENCES PRIVATE LIMITED |
Active
|
10.0 L | 1 | Telangana |
SIRI DRUGS INDIA PRIVATE LIMITED |
Amalgamated
|
7.3 Cr | 2 | Andhra Pradesh |
SARACA LABORATORIES LIMITED |
Active
|
8.0 Cr | 2 | Telangana |
POKARNA ENGINEERED STONE LIMITED |
Active
|
4.2 Cr | 1 | Telangana |
POKARNA LIMITED |
Active
|
6.2 Cr | 1 | Telangana |
EMNAR PHARMA PRIVATE LIMITED |
Active
|
19.9 Cr | 1 | Telangana |
SV REAL HOLDINGS PRIVATE LIMITED |
Active
|
3.4 Cr | 1 | Telangana |
SYNAC PHARMACEUTICALS PRIVATE LIMITED |
Active
|
14.4 L | 1 | Telangana |
ALITHIA PHARMACEUTICALS PRIVATE LIMITED |
Active
|
14.4 L | 1 | Telangana |
AARNA & AKSHAJ INDUSTRIES PRIVATE LIMITED |
Active
|
1.0 L | 1 | Telangana |
PISTA MOTOR RACEWAY LLP |
Active
|
1.0 L | 1 | Telangana |
AZICO PHARMACEUTICALS PRIVATE LIMITED |
Active
|
14.4 L | 1 | Telangana |
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
SV'S REMEDIES LIMITED | India | - | - |
The incorporation date of COVALENT LABORATORIES PRIVATE LIMITED is 13 September, 2002
The authorized share capital of COVALENT LABORATORIES PRIVATE LIMITED is INR ₹ 20.0 Cr.
The paid-up capital of COVALENT LABORATORIES PRIVATE LIMITED is INR ₹ 6.0 Cr.
The registered address of COVALENT LABORATORIES PRIVATE LIMITED is D.NO.8-3-677/18,S.K.D.NAGAR YELLAREDDYGUDA HYDERABAD. Telangana - 500073
The CIN number of COVALENT LABORATORIES PRIVATE LIMITED is U24230TG2002PTC039606.